Eledon Pharmaceuticals Inc. buy Guggenheim
Start price
28.01.25
/
50%
€4.54
Target price
28.01.26
€8.63
Performance (%)
-59.91%
Price
16.01.26
€1.74
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by Guggenheim for Eledon Pharmaceuticals Inc. is performing very badly with a performance of -59.91%. This prediction currently runs until 28.01.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eledon Pharmaceuticals Inc. | 20.833% | 20.833% |
| iShares Core DAX® | 0.191% | 4.771% |
| iShares Nasdaq 100 | -0.614% | 3.137% |
| iShares Nikkei 225® | 0.599% | 8.016% |
| iShares S&P 500 | -0.036% | 3.593% |
Comments by Guggenheim for this prediction
In the thread Eledon Pharmaceuticals Inc. diskutieren
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) is now covered by analysts at Guggenheim. They set a "buy" rating and a $9.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat
Stopped prediction by Guggenheim for Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.34
18.11.25
18.11.25
€6.90
18.11.26
18.11.26
29.10%
16.01.26
16.01.26
